A sensor gives you a moment.
Sinque gives you the story.
The first CGM built to read behavior, not biology — paired with continuous, day-to-day monitoring in Sinque. Fourteen days to discover who your patient really is. Then months of watching for what changes, early enough to act on it.
The shift
Medicine measures biology beautifully. Behavior stays invisible.
Obesity is a behavioral disease with biological consequences — yet behavior has always been the hardest thing to see. The only instrument we had was memory: what did you eat, did you move, how did you sleep? Nobody's lying. Human memory is simply a poor sensor.
So we changed the question — from “is the glucose healthy?” to “what did the patient do?”
Every meal, every late-night snack, every walk after dinner, every skipped breakfast leaves a fingerprint on glucose — objective, involuntary, timestamped. The body remembers what the patient forgot.
We read glucose to learn what a person did.
Two roles, one relay
CGM reads. Sinque remembers.
They aren't two products you choose between. They're a relay — one runs the first leg with precision, then hands the baton to the other, which carries it the rest of the way. One is intense and brief. The other is light and endless.
The start · discovery
CGM — the short calibration
- Role
- A short, high-resolution read of who this person is
- Answers
- “What did this patient do these 14 days?”
- Duration
- ~14 days, then removed
- The patient
- Runs quietly in the background — nothing to track
The continuity · monitoring
Sinque — the long view
- Role
- The light, always-on daily monitoring
- Answers
- “What is this patient doing over months?”
- Duration
- Continuous, indefinitely
- The patient
- Lives in it, seamlessly, every day
Calibrate
CGM reads 14 days — the behavioral baseline.
Translate
The report turns glucose into behavior Sinque can hold.
Monitor
Sinque keeps watch against that baseline — continuous and low-cost — for months.
Recalibrate
Sinque flags real change — triggering the next short wear.
The middle stage is the one people overlook, and it's the most important. Between the sensor and the long view sits a translation — the reports that turn raw glucose into behavior the platform can carry and a professional can act on. Without it, the sensor's insight dies the day it comes off.
The GLP-1 catch
On GLP-1s, the danger flips — and behavior is where you catch it.
These drugs work. But the failure mode inverts: from over-eating to under-eating — skipped meals, too little protein, and muscle lost along with the fat.
The old failure mode
Eating too much
The GLP-1 failure mode
Eating too little
Weight loss still reads as success.
A flat, low glucose rhythm tells a different story. Weight congratulates under-fueling; behavior catches it. Catching it early isn't a nice-to-have — it's a genuine, differentiated safety contribution in the GLP-1 era, and exactly what a behavioral read is built to surface.
The whole idea, in one breath
We're not a weight company. We're not a CGM company. We're the predictive behavioral layer of obesity care.
Earlier intervention. Safer GLP-1 care. And coaching that finally has objective behavioral ground truth to stand on.
A better tomorrow — in view today.